Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Bièche

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Current Opinion in Oncology|November 16, 2010
Genome-based and transcriptome-based molecular classification of breast cancerIvan Bièche, Rosette Lidereau
Bulletin Du Cancer|December 11, 2012
[Chromatin remodeling defects and cancer: the SWI/SNF example]Franck Bourdeaut, Ivan Bièche
Maturitas|July 11, 2006
Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancerIgor Girault, Ivan Bièche, Rosette Lidereau
Pharmacogenomics|June 9, 2017
The SHIVA01 trial: what have we learned?Christophe Le Tourneau, Maud Kamal, Ivan Bièche
Breast Cancer Research and Treatment|February 16, 2013
Response to "comments on the use of a single or multiple probe-set approach for microarray-based analyses of routine molecular markers in breast cancer"Frédérique Spyratos, Ivan Bièche, Patricia de Cremoux
Medecine Sciences : M/S|January 21, 2022
[Starting to integrate artificial intelligence for treatment decisions in oncology]Christophe Le Tourneau, Ivan Bièche, Maud Kamal
Personalized Medicine|September 28, 2018
Precision medicine in oncology: what is it exactly and where are we?Christophe Le Tourneau, Maud Kamal, Ivan Bièche
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomasIgor Girault, Sengül Tozlu, Rosette Lidereau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2010
ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWASEric Pasmant, Audrey Sabbagh, Michel Vidaud, et al.
Molecular Cancer|December 21, 2004
Identification of a three-gene expression signature of poor-prognosis breast carcinomaIvan Bièche, Sengül Tozlu, Igor Girault, et al.
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Current Opinion in Oncology|November 16, 2010
Genome-based and transcriptome-based molecular classification of breast cancerIvan Bièche, Rosette Lidereau
Bulletin Du Cancer|December 11, 2012
[Chromatin remodeling defects and cancer: the SWI/SNF example]Franck Bourdeaut, Ivan Bièche
Maturitas|July 11, 2006
Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancerIgor Girault, Ivan Bièche, Rosette Lidereau
Pharmacogenomics|June 9, 2017
The SHIVA01 trial: what have we learned?Christophe Le Tourneau, Maud Kamal, Ivan Bièche
Breast Cancer Research and Treatment|February 16, 2013
Response to "comments on the use of a single or multiple probe-set approach for microarray-based analyses of routine molecular markers in breast cancer"Frédérique Spyratos, Ivan Bièche, Patricia de Cremoux
Medecine Sciences : M/S|January 21, 2022
[Starting to integrate artificial intelligence for treatment decisions in oncology]Christophe Le Tourneau, Ivan Bièche, Maud Kamal
Personalized Medicine|September 28, 2018
Precision medicine in oncology: what is it exactly and where are we?Christophe Le Tourneau, Maud Kamal, Ivan Bièche
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomasIgor Girault, Sengül Tozlu, Rosette Lidereau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2010
ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWASEric Pasmant, Audrey Sabbagh, Michel Vidaud, et al.
Molecular Cancer|December 21, 2004
Identification of a three-gene expression signature of poor-prognosis breast carcinomaIvan Bièche, Sengül Tozlu, Igor Girault, et al.
Pageof 26